Results 231 to 240 of about 1,940,572 (373)

Multimodal Artificial Intelligence‐Based Virtual Biopsy for Diagnosing Abdominal Lavage Cytology‐Positive Gastric Cancer

open access: yesAdvanced Science, EarlyView.
The multimodal AI‐based RSA model is a powerful tool for diagnosing GC‐CY1, offering significant advantages over traditional diagnostic methods. By combining radiomic and clinical data, the model achieves superior predictive performance, providing a non‐invasive, accurate, and rapid alternative for detecting peritoneal involvement in gastric cancer ...
Ping'an Ding   +15 more
wiley   +1 more source

Synthetic Lethality of SHP2 and XIAP Suppresses Proliferation and Metastasis in KRAS‐mutant Nonsmall Cell Lung Cancer

open access: yesAdvanced Science, EarlyView.
Embelin cotargets SHP2 to disrupt the SHP2/GRB2/SOS complex, inhibiting cancer‐related signaling pathways such as MAPK, (PI3K)/AKT pathway, and XIAP to induce apoptosis signaling pathway, respectively, leading to synthetic lethality in KRAS‐mutant NSCLC cells both in vivo and in vitro.
Nai‐jie Fu   +8 more
wiley   +1 more source

The emerging role of glycolysis and immune evasion in ovarian cancer. [PDF]

open access: yesCancer Cell Int
Jin B   +8 more
europepmc   +1 more source

Targeting the Adenosine‐Mediated Metabolic Immune Checkpoint with Engineered Probiotic for Enhanced Chemo‐Immunotherapy

open access: yesAdvanced Science, EarlyView.
This study presents engineered probiotics that convert immunosuppressive adenosine into inosine in tumors, alleviating immunosuppression and enhancing antitumor immunity. Demonstrating efficacy in murine ectopic and orthotopic tumor models, this approach offers a promising probiotic‐based cancer immunotherapy strategy, highlighting the potential of ...
Jinhui Wang   +11 more
wiley   +1 more source

Amino acid metabolism in glioblastoma pathogenesis, immune evasion, and treatment resistance. [PDF]

open access: yesCancer Cell Int
Srivastava S   +10 more
europepmc   +1 more source

N4‐Acetylcytidine‐Mediated CD2BP2‐DT Drives YBX1 Phase Separation to Stabilize CDK1 and Promote Breast Cancer Progression

open access: yesAdvanced Science, EarlyView.
The long non‐coding RNA (lncRNA) CD2BP2‐DT is upregulated in breast cancer and correlates with poor patient prognosis. Mechanistically, CD2BP2‐DT drives YBX1 phase separation to stabilize CDK1 and promote breast cancer progression. Moreover, NAT10‐mediated N4‐acetylcytosine (ac4C) modification further enhances CD2BP2‐DT expression.
Hongyu Wang   +9 more
wiley   +1 more source

Immune system evasion by peripheral nerve sheath tumor [PDF]

open access: green, 2006
Philip R. Lee   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy